title: Prophylaxis of deep-vein thrombosis after lower extremity amputation: comparison of low molecular weight heparin with unfractionated heparin.
abstract: OBJECTIVE
  To compare the efficacy and safety of a low molecular weight heparin (enoxaparin) with unfractionated heparin (UH) in this prophylaxis.
  
  
  METHODS
  Seventy five patients (59 men and 16 women), undergoing major lower extremity amputation (30 above-knee and 45 below-knee), were randomized to be treated with subcutaneous UH (5,000 IU t.i.d.) or enoxaparin (40 mg/day) during hospitalization. Prophylaxis was started 12 hours before surgery or, in emergency cases, in the first postoperative day.
  
  
  RESULTS
  The two groups were comparable with regard to baseline characteristics. Evaluation of DVT was performed by daily clinical examination and by duplex scanning before and 5 to 8 days after surgery. DVT was documented in the operated limb in 9.75% in patients treated with enoxaparin and in 11.76% in patients treated with UH (p=0.92) and there was one bilateral thrombosis in each group . Bleeding complications were not observed in both groups.
  
  
  CONCLUSIONS
  Enoxaparin and UH were both efficient and safe for the prophylaxis of DVT in patients submitted to lower extremity amputation.
authors.affiliation: Department of Surgery and Orthopedics, SMB, UNESP, São Paulo, Brazil. sidlast@fmb.unesp.br
authors.forename: Sidney
authors.initials: S
authors.lastname: Lastória
authors.forename: Hamilton A
authors.initials: HA
authors.lastname: Rollo
authors.forename: Winston Bonetti
authors.initials: WB
authors.lastname: Yoshida
authors.forename: Mariangela
authors.initials: M
authors.lastname: Giannini
authors.forename: Regina
authors.initials: R
authors.lastname: Moura
authors.forename: Francisco H A
authors.initials: FH
authors.lastname: Maffei
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000671:Amputation, Surgical; D000925:Anticoagulants / Q000627:therapeutic use*; D017984:Enoxaparin / Q000627:therapeutic use*; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007866:Leg / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control*; D011446:Prospective Studies; D017678:Sex Distribution; D020246:Venous Thrombosis / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D017984:Enoxaparin; D006493:Heparin